YILMAZ, A. Et Al. 2020. Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7 , 1791-1794.

YILMAZ, A., Mirili, C., BİLİCİ, M., & TEKİN, S. B., (2020). Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1791-1794.

YILMAZ, Ali Et Al. "Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1791-1794, 2020

YILMAZ, Ali Et Al. "Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1791-1794, 2020

YILMAZ, A. Et Al. (2020) . "Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1791-1794.

@article{article, author={Ali YILMAZ Et Al. }, title={Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={1791-1794} }